Imagine you are sitting in a doctor's office after your annual physical. Your bloodwork is on the screen. Your creatinine is not alarming. Your estimated kidney filtration number, your eGFR, looks acceptable. You hear some version of, 'Your kidneys look fine.' That sounds reassuring. And it may be partly true. But it may not be the whole story. It is possible for a person to have an eGFR that is still in a reassuring range while a urine test is already showing evidence of kidney damage. The blood test and the urine test are not duplicates. They are looking at different parts of kidney health. For men over 40, especially men with high blood pressure, diabetes, heart disease, obesity, a previous kidney injury, or a family history of kidney disease, that distinction matters. The test is called the urine albumin-to-creatinine ratio, usually shortened to UACR. It is simple. It usually requires one urine sample. Yet many people can name their cholesterol, blood sugar, and even testosterone level without knowing whether this kidney number has ever been checked.
Why kidney disease can stay quiet
Your kidneys are often described as filters, but that description understates the job. They remove waste and extra fluid from the blood. They help regulate electrolytes. They influence blood pressure. They help maintain acid balance. They also support red blood cell production and bone health through hormone-related functions.
The problem is that early chronic kidney disease often does not announce itself clearly. You may not feel pain. You may not notice a change in urination. Fatigue, swelling, nausea, itching, and other recognizable symptoms are more likely to appear when disease is more advanced, and those symptoms can have many other causes.
The kidneys also have substantial working reserve. Damage does not have to produce an immediate collapse in total filtration. Remaining nephrons can continue doing enough work to keep the overall filtration estimate from crossing a familiar warning threshold. That is useful for survival, but it also creates a detection problem: preserved function does not always prove that the filtering structures are undamaged.
That helps explain a striking gap between how common chronic kidney disease is and how often people know they have it. In its March 2026 national update, the CDC estimated that about 15 percent of U.S. adults had chronic kidney disease. Most were unaware of it. The estimate for adults ages 45 to 64 was about 13 percent.
Those numbers do not mean that every man over 40 has kidney disease, or that a birthday automatically creates a need for testing. They mean that this is common enough and silent enough that risk deserves attention.
The biggest risk factors are familiar. Diabetes and high blood pressure lead the list. Heart failure and other cardiovascular disease matter. So do obesity, family history, older age, and a history that suggests prior kidney damage.
Here is the important point: turning 40 is not the disease. It is often the stage of life when several risks begin stacking together. A man may have mildly elevated blood pressure, rising blood sugar, extra abdominal weight, and a parent who developed kidney failure, and still feel completely normal. That is exactly why the right measurements matter.
What your eGFR really tells you
When most people say their doctor 'checked their kidneys,' they are usually talking about a blood test for creatinine and the eGFR printed beside it.
Creatinine is a waste product related to normal muscle metabolism. Healthy kidneys remove it from the blood. When filtration falls, creatinine often rises. Laboratories use the creatinine result, along with factors such as age and sex, to estimate the glomerular filtration rate, the amount of blood the kidneys are filtering over time.
That estimate is called eGFR. The 'e' is important. It is not a direct measurement. It is a calculation based on a filtration marker.
For routine care, eGFR is extremely useful. A persistently low value can help identify chronic kidney disease, stage it, follow changes over time, guide medication dosing, and signal when more evaluation may be needed.
But eGFR has limits. First, creatinine is influenced by more than kidney filtration. Muscle mass, body size, diet patterns, serious illness, and rapid changes in kidney function can affect how the number should be interpreted. A muscular man who trains heavily and a frail older man with very little muscle may produce very different amounts of creatinine even if their kidneys filter similarly.
In situations where creatinine may be misleading, or where the result sits near an important clinical decision, health professionals may use another blood marker called cystatin C, sometimes combined with creatinine, to produce a more accurate estimate. That is a refinement of the filtration question.
The second limit is the one at the center of this video: eGFR primarily estimates function, how well the kidneys are filtering. It does not directly ask whether the kidney's filtering barrier is leaking a protein that should largely remain in the bloodstream.
This is a common pattern in medicine. A stress test and a cholesterol test both relate to the heart, but they do not measure the same thing. A fasting glucose and an A1C both relate to blood sugar, but over different time windows. In the same way, eGFR and urine albumin belong to the same kidney story without being interchangeable. For that, we turn to urine.
The urine test looking for damage
Albumin is a protein that circulates in your blood. A healthy kidney's filtration barrier keeps most albumin where it belongs. When that barrier is damaged, albumin can leak into the urine.
The urine albumin-to-creatinine ratio measures the amount of albumin in a urine sample and compares it with the amount of creatinine in that same sample. The ratio helps account for how concentrated or diluted the urine is. That is why a spot UACR can often provide useful information without a 24-hour urine collection.
The result is generally reported in milligrams of albumin per gram of creatinine: milligrams per gram.
A result below 30 milligrams per gram is generally placed in the normal-to-mildly increased category. A result from 30 to 300 is moderately increased. A result above 300 is severely increased.
Those categories do not work like a pass-fail grade. Risk changes across a continuum, and the meaning depends on the eGFR, the trend, the person's medical history, and whether the result persists.
Why divide albumin by urine creatinine? Imagine testing two urine samples from the same person. One was collected after several glasses of water and is very dilute. The other was collected first thing in the morning and is concentrated. The raw albumin concentration could look different simply because of water. Comparing albumin with creatinine helps correct for that dilution. It is not perfect, but it makes a convenient spot sample far more informative than albumin concentration alone.
This test is especially important in diabetes because early increases in albumin can appear before a major fall in eGFR. The American Diabetes Association's 2026 Standards of Care recommend checking both UACR and eGFR at least annually in everyone with type 2 diabetes and in people who have had type 1 diabetes for five years or longer.
KDIGO, the international organization that publishes widely used kidney guidelines, takes the broader principle: people at risk for chronic kidney disease should be evaluated with both urine albumin measurement and an assessment of filtration.
Blood asks, 'How well are the kidneys filtering?' Urine asks, 'Is albumin getting through when it should not?' One measures function. The other can reveal damage. You need to know which question was actually asked.
How one test can look fine while the other does not
Think of kidney health as a map with two coordinates. The first coordinate is eGFR. The second is UACR. Clinical guidelines combine them because the pair gives a more useful picture of kidney and cardiovascular risk than either number alone.
Consider four simplified examples. Person A has an eGFR of 92 and a UACR of 8. Filtration is in a high range, and urine albumin is low. In the absence of other evidence of kidney disease, that pattern is reassuring.
Person B also has an eGFR of 92, but a UACR of 140. The filtration estimate looks preserved, yet the urine is showing moderately increased albumin. If that finding persists, it can qualify as evidence of chronic kidney disease even though the eGFR never looked low.
Person C has a UACR of 10 but an eGFR of 52. The urine albumin is not elevated, but filtration is reduced. If that eGFR remains below 60 for at least three months, that can also meet the definition of chronic kidney disease.
Person D has an eGFR of 45 and a UACR of 400. Both coordinates are abnormal. That pattern generally carries greater risk and deserves prompt clinical attention.
If you have ever seen the colored kidney-risk chart used in clinical guidelines, this is what it is showing. One axis moves from higher to lower eGFR. The other moves from lower to higher albuminuria. The colors progress from lower risk toward greater risk as either coordinate worsens, and especially when both do.
This matters beyond dialysis. Albuminuria and reduced eGFR are associated not only with progression of kidney disease but also with cardiovascular risk and mortality. The kidneys and the cardiovascular system share the same circulation. High blood pressure can damage the kidneys, damaged kidneys can make blood pressure harder to manage, and the risk signals often travel together.
That is why finding albumin in urine can change more than the label on a chart. Depending on the person, it can affect how closely results are followed, how aggressively related risks are managed, and which treatments a clinician considers. The value of the test is not the number itself. It is the chance to make better decisions while there is still time to protect function.
These examples are educational, not a tool for diagnosing yourself. Their purpose is to show why the phrase 'my kidney test was normal' is incomplete until you know which test, and whether the result was repeated when necessary.
The missing information is often not a rare scan or an exotic biomarker. It may be one line on a urine report.
Which men over 40 should discuss both tests?
The most evidence-based answer is not 'every man.' It is 'men whose risk makes the information useful.'
If you have type 2 diabetes, current diabetes guidance clearly supports at least annual eGFR and UACR assessment. If you have type 1 diabetes, the timing depends on how long you have had it, with annual assessment recommended after five years.
If you have high blood pressure, heart failure, cardiovascular disease, obesity, a family history of chronic kidney disease, or a previous episode of acute kidney injury, it is reasonable to ask your clinician whether both filtration and urine albumin should be assessed in your situation.
It is also worth asking if your eGFR has been drifting downward over time, your blood pressure is difficult to control, swelling has appeared, blood has been found in your urine, or another test has raised concern. Those findings do not all mean chronic kidney disease, but they can change the evaluation.
For a healthy man with none of these risks, the case for routine population-wide urine screening is less certain. This is why the message is not, 'Demand this test because you turned 40.' The message is, 'Know your risks, know what was measured, and have a focused conversation.'
A useful question at your next appointment is: 'I see my creatinine and eGFR. Given my blood pressure, blood sugar, family history, and other risks, should I also have a urine albumin-to-creatinine ratio?' That question is specific. It gives your clinician context. And it avoids treating a laboratory test as a product everyone needs to buy.
Why one abnormal result is not the final answer
Suppose your UACR comes back above 30. That does not automatically mean you have permanent chronic kidney disease.
Urine albumin varies. Strenuous exercise can temporarily raise it. A symptomatic urinary infection or blood in the urine can affect the result. Hydration changes the concentration of urine, although using a ratio helps reduce that problem. Differences in muscle mass and creatinine excretion can also influence the ratio.
For those reasons, KDIGO advises repeating an incidentally elevated UACR, low eGFR, or blood in the urine to confirm chronic kidney disease. It specifically warns against assuming chronicity from one abnormal eGFR or ACR result.
A first-morning urine sample is generally preferred when confirming an elevated random UACR. Your clinician may also consider what was happening around the test: a hard workout, an acute illness, an infection, a medication change, or a period of unstable kidney function.
The word 'chronic' refers to persistence over time. In general, kidney abnormalities must be present for at least three months to meet the chronic definition, unless other clinical evidence already establishes chronic disease.
So the right response to one abnormal result is neither panic nor dismissal. It is confirmation, context, and follow-up.
The practical kidney check after 40
Here is a calm, practical way to use this information.
First, get the actual numbers. Do not settle for 'normal' or 'fine.' Look for creatinine, eGFR, and, if it was ordered, UACR. Save the reports so you and your health care team can see the trend.
Second, identify your risk factors. Do you have diabetes? High blood pressure? Heart disease or heart failure? Obesity? A family history of kidney disease? A previous kidney injury? The combination matters more than your age alone.
Third, ask whether both dimensions have been assessed. A metabolic panel may include creatinine and an eGFR, but it does not automatically include a UACR. A routine urine dipstick is also not necessarily the same as a quantitative urine albumin-to-creatinine ratio. Open the laboratory section of your patient portal before the appointment if you can. Search for 'albumin,' 'microalbumin,' 'ACR,' or 'albumin-to-creatinine ratio.' Terminology varies between laboratories. If you find a result, check the unit and date rather than trying to compare numbers from unrelated test types. If you do not find one, that does not prove a mistake was made. It means you now have a focused question about whether the test fits your risk profile.
Fourth, if a result is abnormal, ask what could have influenced it and when it should be repeated. Ask whether the number changes medication dosing, blood pressure goals, diabetes management, follow-up frequency, or the need for a kidney specialist. Do not stop, start, or change a prescription on the basis of a video or one laboratory value.
And fifth, pay attention to the systems that protect both the kidneys and the heart: blood pressure control, blood sugar management when diabetes is present, avoiding tobacco, maintaining a healthy weight, staying active, and reviewing medicines and supplements with a qualified professional. Kidney protection is rarely one miracle product. It is usually a coordinated plan.
Two numbers, one better picture
The hidden lesson is not that the common kidney blood test is bad. eGFR is valuable.
The lesson is that it answers one question.
UACR answers another.
For an at-risk man over 40, a reassuring filtration estimate may coexist with urine albumin that signals damage. The reverse can also happen: urine albumin can be low while filtration is reduced. That is why modern kidney assessment uses the two numbers together.
At your next visit, do not ask only, 'Were my kidneys normal?' Ask, 'What was my eGFR? Was my urine albumin-to-creatinine ratio checked? And what do those results mean together for me?'
That is not self-diagnosis. It is informed participation in your care.
The information in this video is for education and is not a substitute for personal medical advice. Kidney test results must be interpreted in context, and abnormal results often need confirmation. If you have symptoms, rapidly changing results, or concerns about your kidney health, speak with a qualified health professional.
Key takeaways
- A normal eGFR does not rule out kidney damage. It estimates filtration, not whether albumin is leaking into urine.
- UACR measures albumin in urine and can detect damage before eGFR falls.
- Risk categories run from normal to moderately or severely increased albuminuria, but one abnormal result needs confirmation.
- Men with diabetes, high blood pressure, cardiovascular disease, obesity, family history, or prior kidney injury should ask about both tests.
- Repeat testing is needed to confirm chronicity; a first-morning sample is often preferred.
- Kidney protection is a coordinated plan built around blood pressure, blood sugar, weight, activity, tobacco avoidance, and medication review.
References
- Centers for Disease Control and Prevention. Chronic Kidney Disease Surveillance System
- KDIGO. CKD Evaluation and Management
- American Diabetes Association. Standards of Care in Diabetes
How this article is reviewed
Aldrick articles are written from published guidance and peer-reviewed research, checked against our evidence standards and re-reviewed when guidance changes. Spotted something inaccurate or out of date? Tell us and we will correct it and update the review date.
This article is educational. It does not diagnose conditions or replace evaluation by a qualified clinician.
Prefer to watch?
This article is based on our video on preventive health.